\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationTo be confirmed
ProgrammesDuring this event, you will learn all about the wide ranging EIT Community programmes boosting citizen engagements and business acceleration to improve citizen’s quality of life, supporting the New European Bauhaus.
This event is part of the INNOVEIT WEEKS event series of the European Institute of Innovation & Technology. More information and event location coming soon on the event website: innoveit.eu.
This event is organised by the EIT Climate-KIC , which is an EIT knowledge and innovation community working to accelerate the transition to a zero-carbon economy.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
